Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Early combination therapy for the treatment of type 2 diabetes mellitus: systematic review and meta-analysis
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 16, Issue 5, Pages 410-417
Publisher
Wiley
Online
2013-11-10
DOI
10.1111/dom.12233
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology Consensus Panel on Type 2 Diabetes Mellitus: An Algorithm for Glycemic Control
- (2013) Helena Rodbard et al. Endocrine Practice
- Assessment of AACE/ACE Recommendations for Initial Dual Antihyperglycemic Therapy Using the Fixed-Dose Combination of Sitagliptin and Metformin Versus Metformin
- (2013) Samuel Engel et al. Endocrine Practice
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
- (2012) R. R. Henry et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A systematic review of adherence, treatment satisfaction and costs, in fixed-dose combination regimens in type 2 diabetes
- (2011) Valerie Hutchins et al. CURRENT MEDICAL RESEARCH AND OPINION
- Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks
- (2011) A. Pfützner et al. DIABETES OBESITY & METABOLISM
- A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents
- (2011) L. Olansky et al. DIABETES OBESITY & METABOLISM
- A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d
- (2011) J. L. C. Borges et al. DIABETES OBESITY & METABOLISM
- Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time?
- (2010) Bernard Zinman AMERICAN JOURNAL OF MEDICINE
- Effects of Rosiglitazone/Metformin Fixed-Dose Combination Therapy and Metformin Monotherapy on Serum Vaspin, Adiponectin and IL-6 Levels in Drug-Naïve Patients with Type 2 Diabetes
- (2010) N. P. E. Kadoglou et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes
- (2010) Olivia J. Phung JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
- (2009) Alfonso Perez et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study
- (2009) Debora Williams-Herman et al. CURRENT MEDICAL RESEARCH AND OPINION
- Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus
- (2009) E. Bosi et al. DIABETES OBESITY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started